Abstract
Exercise intolerance is a condition where the patient is unable to undertake physical exercise at the level and/or for the duration that would be expected of someone in his or her age and general physical condition. When this inability is triggered by impaired function of one or more of the physiological systems (i.e. central haemodynamic, respiratory, peripheral muscles), the result is the intensification of the perceptions of dyspnoea, often in conjunction with peripheral muscle discomfort that is often triggered by peripheral muscle fatigue [1].
References
Whipp BJ, Wagner PD, Agusti A. Determinants of the physiological systems responses to muscular exercise in healthy subjects. In:European respiratory monograph. United Kingdom: European Respiratory Society; 2007. p. 30–4.
O’Donnell DE, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155(1):109–15.
Wagner PD. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol. 1996;58:21–50.
Mador MJ, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(2 Pt 1):447–53.
Roca J, et al. Guidelines for interpretation. In: Roca J, Whipp BJ, editors. European respiratory monograph. United Knigdom: European Respiratory Society; 1997. p. 88–114.
Killian KJ. Limitation to muscular activity in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):6–7.
Palange P, et al. Recommendation on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:185–209.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.
Singh SJ, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–24.
Revill SM, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999;54(3):213–22.
Troosters T, et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002;20(3):564–9.
Onorati P, et al. Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol. 2003;89(3–4):331–6.
Rice AJ, et al. Pulmonary gas exchange during exercise in highly trained cyclists with arterial hypoxemia. J Appl Physiol. 1999;87(5):1802–12.
Richardson RS, et al. Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am J Phys. 1995;268(4 Pt 2):H1453–61.
Saltin B, Calbet JA, Wagner PD. Point: in health and in a normoxic environment, VO2 max is limited primarily by cardiac output and locomotor muscle blood flow. J Appl Physiol. 2006;100:744–8.
Ekblom B, Hermansen L. Cardiac output in athletes. J Appl Physiol. 1968;25(5):619–25.
Grimby G, Nilsson NJ, Saltin B. Cardiac output during submaximal and maximal exercise in active middle-aged athletes. J Appl Physiol. 1966;21(4):1150–6.
Mitchell JH, Sproule BJ, Chapman CB. The physiological meaning of the maximal oxygen intake test. J Clin Invest. 1958;37(4):538–47.
Saltin B. Circulatory response to submaximal and maximal exercise after thermal dehydration. J Appl Physiol. 1964;19:1125–32.
Koskolou MD, et al. Cardiovascular responses to dynamic exercise with acute anemia in humans. Am J Phys. 1997;273(4 Pt 2):H1787–93.
Stenberg J, Ekblom B, Messin R. Hemodynamic response to work at simulated altitude, 4,000 m. J Appl Physiol. 1966;21(5):1589–94.
Roach RC, et al. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Phys. 1999;276(2 Pt 2):H438–45.
Ekblom B, Wilson G, Astrand PO. Central circulation during exercise after venesection and reinfusion of red blood cells. J Appl Physiol. 1976;40(3):379–83.
Krip B, et al. Effect of alterations in blood volume on cardiac function during maximal exercise. Med Sci Sports Exerc. 1997;29(11):1469–76.
Torre-Bueno JR, et al. Diffusion limitation in normal humans during exercise at sea level and simulated altitude. J Appl Physiol. 1985;58(3):989–95.
Gledhill N, Froese AB, Dempsey JA. Ventilation to perfusion distribution during exercise in health. In: Dempsey JA, Reed CE, editors. Muscular exercise and the lung. Wisconsin: University of Wisconsin; 1977. p. 325–44.
Powers SK, et al. Effects of incomplete pulmonary gas exchange on VO2 max. J Appl Physiol. 1989;66(6):2491–5.
O’Donnell DE, Ofir D, Laveneziana P. Patterns of cardiopulmonary response to exercise in lung diseases. In:European respiratory monograph. United Kingdom: European Respiratory Society; 2007. p. 69–92.
Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003a;107(1):139–46.
Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003b;107(2):346–54.
Marcinek DJ, et al. Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle. J Physiol. 2005;569(Pt 2):467–73.
DeLorey DS, Paterson DH, Kowalchuk JM. Effects of ageing on muscle O2 utilization and muscle oxygenation during the transition to moderate-intensity exercise. Appl Physiol Nutr Metab. 2007;32(6):1251–62.
DeLorey DS, Babb TG. Progressive mechanical ventilatory constraints with aging. Am J Respir Crit Care Med. 1999;160(1):169–77.
Stathokostas L, et al. Longitudinal changes in aerobic power in older men and women. J Appl Physiol. 2004;97(2):781–9.
Coggan AR, et al. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol. 1992;47(3):B71–6.
Russell JA, et al. Effects of aging on capillary geometry and hemodynamics in rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol. 2003;285(1):H251–8.
Taylor BJ, Johnson BD. The pulmonary circulation and exercise responses in the elderly. Semin Respir Crit Care Med. 2010;31(5):528–38.
Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol. 1968;25(6):664–71.
Walsh J, et al. Structural change of the thorax in chronic obstructive pulmonary disease. J Appl Physiol. 1992;72:1270–8.
Tolep K, et al. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med. 1995;152(2):677–82.
Johnson BD, Badr MS, Dempsey JA. Impact of the aging pulmonary system on the response to exercise. Clin Chest Med. 1994;15(2):229–46.
Johnson BD, et al. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am Rev Respir Dis. 1991;143(5 Pt 1):960–7.
Johnson BD, et al. Mechanical constraints on exercise hyperpnea in a fit aging population. Am Rev Respir Dis. 1991;143(5 Pt 1):968–77.
Harms CA, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol. 1997;82(5):1573–83.
Aliverti A, et al. Human respiratory muscle actions and control during exercise. J Appl Physiol. 1997;83(4):1256–69.
Vogiatzis I, et al. Respiratory kinematics by optoelectronic plethysmography during exercise in men and women. Eur J Appl Physiol. 2005;93(5–6):581–7.
Vogiatzis I, et al. Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV. Eur Respir J. 2008;32(1):42–52.
Gallagher C. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med. 1994;15(2):305–26.
American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.
Harms CA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol. 2006;151(2–3):124–31.
Wasserman K, et al. Exercise testing and interpretation: an overview. In: Weinberg WR, editor. Principles of exercise testing and interpretation. Baltimore, PA: Lippincott Williams & Wilkins; 2005. p. 1–9.
Dillard TA, Piantadosi S, Rajagopal KR. Prediction of ventilation at maximal exercise in chronic airflow obstruction. Am Rev Respir Dis. 1985;132:230–5.
Laveneziana P, Parker CM, O’Donnell DE. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. Appl Physiol Nutr Metab. 2007;32(6):1225–38.
MacIntyre NR. Mechanisms of functional loss in patients with chronic lung disease. Respir Care. 2008;53(9):1177–84.
Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol. 1968;25(1):21–7.
MacIntyre NR, Leatherman NE. Mechanical loads on the ventilatory muscles. A theoretical analysis. Am Rev Respir Dis. 1989;139(4):968–73.
Casaburi R, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991;143(1):9–18.
O’Donnell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. In: Weisman I, Zeballos R, editors. Progress in respiratory research. Basel: Karger; 2002. p. 138–58.
West JB. State of the art: ventilation-perfusion relationships. Am Rev Respir Dis. 1977;116(5):919–43.
Agusti A, Cotes J, Wagner P. Responses to exercise in lung diseases. In:European respiratory monograph. UK: ERS Journals; 1997. p. 32–50.
Hyatt RE. Expiratory flow limitation. J Appl Physiol. 1983;55(1 Pt 1):1–7.
Martinez FJ, et al. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997;155(6):1984–90.
O’Donnell DE, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med. 2001;164:770–7.
Ferrazza A, et al. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77:3–17.
Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):20–2.
Agusti AG, et al. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest. 1990;97(2):268–75.
Agusti AG, et al. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;143(2):219–25.
D’Alonzo GE, et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest. 1987;92(1):57–62.
Dantzker DR, D’Alonzo GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134(6):1135–9.
Dantzker DR, et al. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. Am Rev Respir Dis. 1984;130(3):412–6.
Janicki JS. Influence of the pericardium and ventricular interdependence on left ventricular diastolic and systolic function in patients with heart failure. Circulation. 1990;81(2 Suppl):III15–20.
Dempsey JA, Harms CA, Ainsworth DM. Respiratory muscle perfusion and energetics during exercise. Med Sci Sports Exerc. 1996;28(9):1123–8.
Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med Sci Sports Exerc. 1996;153(3):976–80.
Hamilton AL, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2021–31.
Bernard S, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629–34.
Serres I, et al. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 1998;113(4):900–5.
Booth F, Gollnick P. Effects of disease on the structure and function of skeletal muscle. Med Sci Sports Exerc. 1983;15(5):415–20.
Coyle EF, et al. Effects of detraining on responses to submaximal exercise. J Appl Physiol. 1985; 59(3):853–9.
Mainguy V, et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65(2):113–7.
Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol. 2012;2(3):1779–817.
Johnson B. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.
Puente-Maestu L, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–60.
Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014;43(6):1750–62.
Banzett RB, O’Donnell CR. Should we measure dyspnoea in everyone? Eur Respir J. 2014;43(6):1547–50.
Gronseth R, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.
Nishimura K, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–40.
Abidov A, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med. 2005;353(18):1889–98.
Ho SF, et al. Dyspnoea and quality of life in older people at home. Age Ageing. 2001;30(2):155–9.
Hayton C, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401–7.
Parshall MB, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.
Laveneziana P, et al. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med. 2011;184(12):1367–73.
Laveneziana P, et al. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? Respir Physiol Neurobiol. 2014;199:24–33.
O’Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol. 2006;101(4):1025–35.
Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J. 2012;40(2):322–9.
Hudson AL, Laveneziana P. Do we “drive” dyspnoea? Eur Respir J. 2015;45(2):301–4.
Lanini B, et al. Perception of dyspnea in patients with neuromuscular disease. Chest. 2001;120(2):402–8.
O’Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol. 1998;84(6):2000–9.
O’Donnell DE, et al. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med. 1999;160(6):1804–11.
Laveneziana P, et al. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. J Appl Physiol. 2009;106(5):1574–83.
Laveneziana P, et al. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2013;41(3):578–87.
Laveneziana P, et al. Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations. Eur Respir J. 2014;44(4):1069–72.
Laveneziana P, et al. Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2015;45(5):1495–8.
DeLorey DS, Wyrick BL, Babb TG. Mild-to-moderate obesity: implications for respiratory mechanics at rest and during exercise in young men. Int J Obes. 2005;29(9):1039–47.
Ofir D, et al. Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol. 2007;102(6):2217–26.
Romagnoli I, et al. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects. Acta Physiol (Oxford). 2008;193(4):393–402.
Laveneziana P, et al. Tidal volume inflection and its sensory consequences during exercise in patients with stable asthma. Respir Physiol Neurobiol. 2012;185(2):374–9.
Laveneziana P, et al. Mechanisms of dyspnoea and its language in patients with asthma. Eur Respir J. 2006;27(4):742–7.
Lougheed MD, Fisher T, O’Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest. 2006;130(4):1072–81.
Moy ML, et al. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med. 2000;162(2 Pt 1):451–5.
Lougheed MD, et al. Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis. 1993;148(6 Pt 1):1452–9.
Ottanelli R, et al. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest. 2001;120(3):770–7.
Ottanelli R, et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci (Lond). 2000;98(6):681–7.
Killian KJ, et al. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med. 2000;162(2 Pt 1):490–6.
Gorini M, et al. Chest wall hyperinflation during acute bronchoconstriction in asthma. Am J Respir Crit Care Med. 1999;160(3):808–16.
Filippelli M, et al. Overall contribution of chest wall hyperinflation to breathlessness in asthma. Chest. 2003;124(6):2164–70.
Moy ML, et al. Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol. Am J Respir Crit Care Med. 1998;158(3):749–53.
Barreiro E, et al. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J. 2004;24(2):219–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Vogiatzis, I., Palange, P., Laveneziana, P. (2018). Assessment of Exercise Capacity. In: Clini, E., Holland, A., Pitta, F., Troosters, T. (eds) Textbook of Pulmonary Rehabilitation. Springer, Cham. https://doi.org/10.1007/978-3-319-65888-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-65888-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-65887-2
Online ISBN: 978-3-319-65888-9
eBook Packages: MedicineMedicine (R0)